Masimo Debt to Equity Ratio 2007-2018 | MASI

Current and historical debt to equity ratio values for Masimo (MASI) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Masimo debt/equity for the three months ending September 30, 2018 was 0.00.
Masimo Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-09-30 $0.00B $0.91B 0.00
2018-06-30 $0.00B $0.83B 0.00
2018-03-31 $0.00B $0.77B 0.00
2017-12-31 $0.00B $0.72B 0.00
2017-09-30 $0.00B $0.72B 0.00
2017-06-30 $0.00B $0.71B 0.00
2017-03-31 $0.00B $0.63B 0.00
2016-12-31 $0.00B $0.56B 0.00
2016-09-30 $0.15B $0.33B 0.46
2016-06-30 $0.18B $0.30B 0.59
2016-03-31 $0.23B $0.27B 0.84
2015-12-31 $0.19B $0.28B 0.67
2015-09-30 $0.19B $0.27B 0.71
2015-06-30 $0.18B $0.28B 0.63
2015-03-31 $0.13B $0.33B 0.39
2014-12-31 $0.13B $0.31B 0.41
2014-09-30 $0.00B $0.28B 0.00
2014-06-30 $0.00B $0.32B 0.00
2014-03-31 $0.00B $0.35B 0.00
2013-12-31 $0.00B $0.33B 0.00
2013-09-30 $0.00B $0.31B 0.00
2013-06-30 $0.00B $0.29B 0.00
2013-03-31 $0.00B $0.28B 0.00
2012-12-31 $0.00B $0.28B 0.00
2012-09-30 $0.00B $0.31B 0.00
2012-06-30 $0.00B $0.30B 0.00
2012-03-31 $0.00B $0.28B 0.00
2011-12-31 $0.00B $0.28B 0.00
2011-09-30 $0.00B $0.30B 0.00
2011-06-30 $0.00B $0.28B 0.00
2011-03-31 $0.00B $0.26B 0.00
2010-12-31 $0.00B $0.23B 0.00
2010-09-30 $0.00B $0.25B 0.00
2010-06-30 $0.00B $0.23B 0.00
2010-03-31 $0.00B $0.21B 0.00
2009-12-31 $0.00B $0.29B 0.00
2009-09-30 $0.00B $0.27B 0.00
2009-06-30 $0.00B $0.25B 0.00
2009-03-31 $0.00B $0.24B 0.00
2008-12-31 $0.00B $0.22B 0.00
2008-09-30 $0.00B $0.21B 0.00
2008-06-30 $0.00B $0.19B 0.00
2008-03-31 $0.00B $0.17B 0.00
2007-12-31 $0.02B $0.15B 0.13
2007-09-30 $0.02B $0.14B 0.16
2007-06-30 $0.03B $-0.02B -1.67
2007-03-31 $0.00B $0.00B 0.00
2006-09-30 $0.00B $0.00B 0.00
2006-06-30 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $5.518B $0.798B
Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $93.752B 21.85
Intuitive Surgical (ISRG) United States $55.121B 54.23
Edwards Lifesciences (EW) United States $31.332B 33.53
Fresenius Medical Care AG KGaA (FMS) Germany $23.909B 16.19
IDEXX Laboratories (IDXX) United States $16.688B 47.67
ABIOMED (ABMD) United States $13.504B 97.03
Teleflex (TFX) United States $11.637B 26.42
Hologic (HOLX) United States $11.312B 18.56
DexCom (DXCM) United States $10.778B 0.00
Varian Medical Systems (VAR) United States $10.561B 26.16
STERIS (STE) United Kingdom $9.781B 25.95
LivaNova (LIVN) United Kingdom $5.850B 37.55
Globus Medical (GMED) United States $4.957B 31.07
Integra LifeSciences Holdings (IART) United States $4.461B 21.73
Penumbra (PEN) United States $4.256B 256.98
Cantel Medical (CMD) United States $3.570B 35.95
Wright Medical Group (WMGI) Netherlands $3.567B 0.00
Inogen (INGN) United States $2.935B 63.34
Integer Holdings (ITGR) United States $2.691B 22.52
Halyard Health (AVNS) United States $2.244B 20.22
Glaukos (GKOS) United States $1.974B 0.00
OPKO Health (OPK) United States $1.931B 0.00
Tandem Diabetes Care (TNDM) United States $1.723B 0.00
Mazor Robotics (MZOR) Israel $1.535B 0.00
Luminex (LMNX) United States $1.183B 42.81
Nevro (NVRO) United States $1.136B 0.00
Natus Medical (BABY) United States $1.128B 23.68
Pacific Biosciences Of California (PACB) United States $1.118B 0.00
Orthofix (OFIX) United States $1.095B 31.64
AxoGen (AXGN) United States $1.087B 0.00
CryoLife (CRY) United States $1.036B 90.87
Tactile Systems Technology (TCMD) United States $1.016B 161.82
Intersect ENT (XENT) United States $0.907B 0.00
AngioDynamics (ANGO) United States $0.783B 27.40
Mesa Laboratories (MLAB) United States $0.773B 45.69
Accelerate Diagnostics (AXDX) United States $0.719B 0.00
TransEnterix (TRXC) United States $0.646B 0.00
ViewRay (VRAY) United States $0.645B 0.00
Veracyte (VCYT) United States $0.552B 0.00
Sientra (SIEN) United States $0.482B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.418B 0.00
Accuray (ARAY) United States $0.387B 0.00
SI-BONE INC (SIBN) United States $0.386B 0.00
Quotient (QTNT) Switzerland $0.380B 0.00
OrthoPediatrics (KIDS) United States $0.347B 0.00
Fluidigm (FLDM) United States $0.324B 0.00
SeaSpine Holdings (SPNE) United States $0.302B 0.00
Nuvectra (NVTR) United States $0.297B 0.00
IRadimed (IRMD) United States $0.293B 76.63
Neuronetics (STIM) United States $0.281B 0.00
GenMark Diagnostics (GNMK) United States $0.280B 0.00
RTI Surgical (RTIX) United States $0.272B 42.90
Corindus Vascular Robotics (CVRS) United States $0.230B 0.00
Pulse Biosciences (PLSE) United States $0.226B 0.00
CRH Medical (CRHM) Canada $0.225B 38.75
Helius Medical Technologies (HSDT) United States $0.187B 0.00
T2 Biosystems (TTOO) United States $0.183B 0.00
Ekso Bionics Holdings (EKSO) United States $0.122B 0.00
Alphatec Holdings (ATEC) United States $0.120B 0.00
Ra Medical Systems (RMED) United States $0.105B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.095B 0.00
Sensus Healthcare (SRTS) United States $0.095B 0.00
Second Sight Medical Products (EYES) United States $0.087B 0.00
Apollo Endosurgery (APEN) United States $0.078B 0.00
EDAP TMS (EDAP) France $0.075B 0.00
Restoration Robotics (HAIR) United States $0.070B 0.00
Viveve Medical (VIVE) United States $0.066B 0.00
Biosig Technologies (BSGM) United States $0.062B 0.00
Electromed (ELMD) United States $0.048B 23.12
OBALON THERPTCS (OBLN) United States $0.045B 0.00
Xtant Medical Holdings (XTNT) United States $0.042B 0.00
Vermillion (VRML) United States $0.038B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.035B 0.00
Lianluo Smart (LLIT) China $0.031B 0.00
ConforMIS (CFMS) United States $0.030B 0.00
Titan Medical (TMDI) Canada $0.027B 0.00
PAVmed (PAVM) United States $0.027B 0.00
Neovasc (NVCN) Canada $0.024B 0.00
Dynatronics (DYNT) United States $0.023B 0.00
ENDRA Life Sciences (NDRA) United States $0.021B 0.00
DarioHealth (DRIO) Israel $0.018B 0.00
American Shared Hospital Services (AMS) United States $0.015B 11.17
Bioanalytical Systems (BASI) United States $0.014B 0.00
Nanovibronix (NAOV) United States $0.013B 0.00
Presbia (LENS) Ireland $0.013B 0.00
Cesca Therapeutics (KOOL) United States $0.010B 0.00
Micron Solutions (MICR) United States $0.009B 0.00
Microbot Medical (MBOT) United States $0.009B 0.00
ReWalk Robotics (RWLK) Israel $0.008B 0.00
Allied Healthcare Products (AHPI) United States $0.008B 0.00
InspireMD (NSPR) Israel $0.008B 0.00
Sunshine Heart Inc (CHFS) United States $0.007B 0.00
Atossa Genetics (ATOS) United States $0.007B 0.00
Avinger (AVGR) United States $0.003B 0.00
Amedica (SINT) United States $0.003B 0.00
EnteroMedics (RSLS) United States $0.000B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00